Percutaneous Ultrasound-guided Padiofrequency Ablation for Solitary Benign Nodular Thyroid Disease: Preliminary Report
Main Article Content
Abstract
Percutaneous Ultrasound-guided Padiofrequency Ablation for Solitary Benign Nodular Thyroid Disease: Preliminary Report
Warurt Manosittisak MD*
Jesada Suvikrom MD**
Wallaya Jongjaroenprasert MD***
*Endocrinology Unit, Department of Medicine, BMA Medical College and Vajira Hospital
**Radiodiagnostic Unit, Department of Radiology, Ramathibodi Hospital
***Endocrinology and Metabolism Unit, Department of Medicine, Ramathibodi Hospital
Objective: To determine the preliminary results of percutaneous radiofrequency ablation in reducing the volume of solitary benign nodular thyroid lesions.
Study design: Case series.
Subjects: Five euthyroid patients with solitary solid thyroid nodule and benign cytological finding attending Endocrine Clinic, Department of Medicine, and Ramathibodi Hospital during January 2004 to June 2005 were selected
Methods: All patients underwent one session of ultrasound-guided radiofrequency ablation (RFA). After infiltrating local anesthetic agent, a 18-gauge needle with 1.5-inch length was inserted into the thyroid nodule. Then, an
electrode was placed through the needle into the lesion. RFA was applied with an output power of 5 W for 10-15 minutes to obtain the internal temperature of 90o C. The result of RFA was evaluated by measuring the volume with ultrasonography at 1 month, 4 months and 6 months after treatment. Procedure-related complications were also recorded.
Main outcome measures: Volume of thyroid nodule before and after treatment, procedure-related complication.
Results: There were four females and one male with the mean age of 46.8 years. Nodule volume ranged from 7.7 to 27.9 cm3. Mean volume before and 6 moth after treatment in all cases were 13.7: 11.8, 14.1: 13.1, 27.9: 9.9, 9.9: 4.3 and 7.7: 1.5 cm3 respectively. The size decreased with the range of 7.5-80.2% comparing with before treatment. The reduction in size could be observed at1 month after treatment in all cases. There was no procedure-related complication.
Conclusion: In this preliminary result, RFA decreased the volume of solitary benign thyroid nodular diseases without any complication within 6 months after treatment.
Key word: benign thyroid nodule, radiofrequency ablation, volume
Vajira Med J 2006 ; 50 : 145 - 151